Filippo Perrini
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificial Intelligence Paradigm.
Journal: Current neuropharmacology
Published: May 12, 2025
Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder.
Journal: Current neuropharmacology
Published: July 26, 2024
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study.
Journal: Frontiers in psychiatry
Published: October 13, 2023
Burnout and Psychological Vulnerability in First Responders: Monitoring Depersonalization and Phobic Anxiety during the COVID-19 Pandemic.
Journal: International journal of environmental research and public health
Published: January 27, 2022
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.
Journal: Current neuropharmacology
Published: November 19, 2021
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: June 16, 2021
Developmental trajectories in psychiatric disorders: does substance/alcohol use moderate the effects of affective temperaments as moderators of age at onset? A study in post-acute, hospitalized patients with psychotic or DSM-5 bipolar or major depressive disorders.
Journal: Journal of addictive diseases
Published: February 15, 2021
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder.
Journal: Current neuropharmacology
Published: September 28, 2020
Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory Analysis.
Journal: Frontiers in psychiatry
Published: July 19, 2019
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.
Journal: Neuropsychiatric disease and treatment
Published: June 29, 2018
The problem of overcontrol: Perfectionism, emotional inhibition, and personality disorders.
Journal: Comprehensive psychiatry
Published: August 31, 2017
Emotion dysregulation, symptoms, and interpersonal problems as independent predictors of a broad range of personality disorders in an outpatient sample.
Journal: Psychology and psychotherapy
Published: August 23, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026